ࡱ> ` `bjbjss X \*\*\*8*l+lgQ6x+(++++[.J..PPPPPPP$ShV Q 0-^[. 0 0 Q++]!Q777 0f++P7 0P776MbP+l+ 0M\*4OP7Q0gQ6O`VT7V8PPVP(.0/"7#/?/... Q QT7R...gQ 0 0 0 0#\*\*  Department of Counseling and Family Therapy Saint Joseph College COUN 564 Psychopharmacology for the Non-medical Mental Health Clinician (online) Credits: 3 Summer 2010 Judith C. Durham, APRN, PhD, LPC.  HYPERLINK "mailto:jdurham@sjc.edu" jdurham@sjc.edu (860) 716 7266 (cell) Course Description: This course will prepare counselors to provide services in conjunction with a psychopharmacological prescriber. Content will include the merger of psychotherapy and pharmacotherapy, history, efficacy and present standard of care. Ethical and legal issues for the non-medical counselor relating to pharmacotherapy will be covered. Numerous case examples demonstrating appropriate psychopharmacologic management, and strategies for developing a collaborative relationship with the prescriber will be presented. Course Objectives: Provide the non medical mental health clinician the necessary background in neuroanatomy and neurophysiology to be able to understand psychopharmacology. Assist students in developing a clinical perspective into psychotropic drug usage as an adjunct to other forms of therapy. Provide students with the major categories of psychotropic medications and the commonly used drugs within each of those categories. Provide students with an understanding of the pharmacodynamics and pharmacokenetics of psychotropic medication to assist clients in monitoring efficacy and side effects. Teach students how to form effective working relationships with psychopharmacological prescribers. Provide students with an understanding of the role of the FDA in psychopharmacology. Pre-requsite: A working knowledge and understanding of DSM diagnoses or Successful completion of COUN 544. Course Outcomes: At the completion of this course, students will: Possess knowledge of the major categories of psychotropic medications and understand their psychologic and physiologic reactions within the body. Be able to educate clients regarding the side effects and efficacy of medications. Be able to advocate for clients with the prescribing individual. Required Texts:  Bezchlibnyk-Butler, K.Z. & Jeffries, J.J. (2009). Clinical Handbook of Psychotropic Drugs (18th ed.). Seattle: Hogrefe & Huber Pulb. Bezchlibnyk-Butler, K.Z. & Virani, A. S. (200?). Clinical Handbook of Psychotropic Drugs for Children andAdolescents (latest ed.) Seattle: Hogrefe & Huber Pulb. Sinacola, R.S. & Peters-Strickland, T. (2006). Basic Pharmacology for Counselors and Psychotherapists. Boston, MA: Pearson Education, Inc. Course Requirements: This is an asynchronous on line class clustered into nine (9) learning units (LU). Learning units must be completed sequentially and spaced over the semester. Each learning unit includes a lecture (power point format), an assignment and an online discussion. Students must participate in the course discussion in a manner that demonstrates active engagement with the material. Sometimes the answers to the questions will be found in the course material, other times students must look to the web for answers. Students are also expected to read each others posts within the discussion board and respond thoughtfully. Assignments must be posted (when so assigned) or placed in the digital drop box as attachments in MS Word or text format. Professor will be processing email twice a week. However, students are encouraged to post generic questions in the course conference under the heading of "Questions to Instructor" in order that all students may benefit from the information as one would in an actual classroom setting. Please do not email professor with general course questions. Professor will be responding to the questions in this folder 2-3 times each week, so please do not expect daily responses. Students should be comfortable working in an online medium, be able to navigate the web with relative ease, and be able to send files electronically. Although not absolutely necessary, it is recommended that students have a DSL or satellite connection. Students must also obtain an SJC e-mail account and check it regularly. All correspondence from Blackboard uses only the SJC email system. Following completion of learning Units 5, 6, 7, & 8, students will submit to instructor an analysis of the posted case examples discussing medication issues, hypotheses regarding pharmacodynamics, side effect manifestations, and hypothetical discussion with prescribing physician including treatment recommendations. Paper must be well written and in APA format; approximately 3-5 pages exclusive of references. Papers are to be posted in the digital drop box. It is required that students refer to texts, posted course material, as well as online resources to complete these assignments. Course Evaluation and Grading  Through the online Discussion and responses formulated to the questions posed by the instructor, students must demonstrate active engagement with and mastery of the material. Total points - 40, 5 for each learning unit. The grading criteria for the Discussion Board is as follows: 1 point for responding to the question. 2 points if your response integrated material from the text or ppt. and includes appropriate citations. 3 points if your response includes material from the text or ppt.s or integrates information/research from the Web including appropriate citations and URL. 4 points if your response includes material from the text or ppt.s and integrates information/research from the Web including appropriate citations and URL. 5 points if you do an especially detailed of the above. Because this is an asynchronous class, students may work at their own pace in completing the learning units. However, in order to spread the work load across the summer session, case analyses will have a due date by which they must be completed, although students may submit them earlier. Case 1 - June 16: Case 2 June 30; Case 3 15; Case 4 - July 28; Associated learning units must be completed before the corresponding case analyses. All Black Board Discussion assignments and case analyses must be completed by July 28. NO exceptions will be made. Analyses of case examples must demonstrate comprehension of the material including appropriate diagnosis, pharmacokinetics, pharmacodynamics, and clinical wisdom. They must also integrate course readings and material from the internet. Papers are to be written in APA format, and be 3-5 pages in length excluding references. (Please do not exceed the 5 page limit.) I recommend that you consult the American Psychological Association Publication Manual, 6th ed. (2009) (APA). Papers must be well organized, express concepts in a clear and fluid manner, and develop ideas with enough elaboration and detail to adequately cover the subject. The proper mechanics of writing (i.e. spelling, punctuation, verb tense) is a must. Total Points 60, 15 for each paper. 15 points: Written using APA style of citations and referencing. Integration of all salient information from ppts. and other posted material, text, and information from web based sources. 14 points: Written using APA style of citations and referencing. Integration of essential information from ppts. text, and web based information. 13 points: Written using APA style of citations and referencing. Paper is basically accurate, although some salient information from text, ppts or web based sources is missing. 12 points: Not written using APA Style, or essential information from text, ppts or web based sources is missing. Academic Integrity Absolute integrity is expected of every student in all academic undertakings. An atmosphere of academic integrity is inherent in the philosophy of Saint Joseph College and shall be upheld by all members of this community. Academic integrity is the responsibility a student assumes for honestly representing all academic work. This responsibility implies the student will in no way either misrepresent her or his work or unfairly advance her or his academic status and will neither encourage nor assist another student in so doing. Academic work includes quizzes, tests, mid-term examinations, final examinations, research projects, take-home assignments, laboratory work, and all other forms of oral or written academic endeavor. Any breach of the academic integrity policy will be addressed immediately in accordance with Saint Joseph College guidelines. (2005-2007, Graduate Catalog, p.8) Documented Disability: Important Notice to All Students: Saint Joseph College is committed to ensure the full participation of all students in its programs. Accordingly, if a student has a documented disability, and, as a result, needs reasonable accommodation(s) to attend, participate, or complete course requirements, then he or she should inform the instructor at the beginning of the course. For further information about services through Saint Joseph College for students with disabilities, contact the Coordinator of Disability Services. To be provided with reasonable accommodation(s) you must present appropriate full documentation of your disability to the Coordinator of Disability Services. Please consult with your professor and contact the Coordinator of Disability Services at 860-231-5366. Professional Readiness Statement: The Faculty of the Counselor Education Program recognize their ethical obligation to monitor the readiness of those wishing to enter the counseling profession. The Ethical Code of the American Counseling Association (ACA), section F.9.a., holds that counselor educators are obligated to address personal and professional limitations of students and supervisees. Section F.9.a. of the ACA Code of Ethics (2006) states: F.9. Evaluation and Remediation of Students F.9.a. Evaluation Counselors clearly state to students, prior to and throughout the training program, the levels of competency expected, appraisal methods, and timing of evaluations for both didactic and clinical competencies. Counselor educators provide students with ongoing performance appraisal and evaluation feedback throughout the training program. F.9.b. Limitations Counselor educators, through ongoing evaluation and appraisal, are aware of and address the inability of some students to achieve counseling competencies that might impede performance. Counselor educators 1. assist students in securing remedial assistance when needed, 2. seek professional consultation and document their decision to dismiss or refer students for assistance, and 3. ensure that students have recourse in a timely manner to address decisions to require them to seek assistance or to dismiss them and provide students with due process according to institutional policies and procedures. The Faculty take their ethical responsibilities stated and implied with in the ACA Code of Ethics seriously. Therefore, the Faculty will function as an educational team to assess and monitor the presence of any limitations that may impede a student's progress within the program and/or in the delivery of counseling services. This assessment will address academic and non-academic (interpersonal functioning) aspects of the student's performance. The Faculty will meet once each semester to assess each student's progress in academic and personal development domains and make recommendations regarding specific concerns. If a student discloses personal information to a Faculty member, that faculty member may share that information with other appropriate faculty. Such information will only be shared to the extent necessary to assess the student's ability to serve in the role of a professional counselor. Faculty members may also consult each other if it is observed that a student behaves in a manner that is inappropriate, unprofessional, and/or raises questions regarding that student's readiness for the profession. Faculty will address issues of readiness with individual students as detailed in the 2009-2010 Counselor Education Student Handbook. Additional Recommended Texts & Readings: Coyle, J.T. (2000). Psychotropic drug use in very young children. JAMA, 283, 1059-1060. Julien, R. M. (2001). A Primer of Drug Action: A concise non-technical guide to the actions, uses and side effects of psychotropic drugs (9th ed.) New York: W.H. Freeman & Co. King, J. H., & Anderson, S. M. (2004). Therapeutic implications of pharmacotherapy: Current trends and ethical issues. Journal of Counseling & Development, 82, 329-336. Smith, T. (2005). Psychopharmacology & Psychotherapy: Ethical considerations for the clinical practitioner. TN: Cross Country Education, Inc. Stahl, S.M. (2004). Essential psychophamacology: Neuroscientific basis and practical applications, (2nd ed). Cambridge University Press. Class Outline Because this is an asynchronous class, students may work at their own pace in completing the learning units. However, in order to spread the work load across the summer session, case analyses will have a due date by which they must be completed, although students may submit them earlier. Case 1 - June 16: Case 2 June 30; Case 3 15; Case 4 - July 28; Associated learning units must be completed before the corresponding case analyses. All Black Board Discussion assignments and case analyses must be completed by July 28. NO exceptions will be made. Learning Unit 1 Counselors Role in psychopharmacology Ethical Issues, The Role of the FDA Diagnosis is essential. READ: Sinacola, chapt 1 & 4. Discussion Board Questions: 1. Introductions: Since this is the first class session and many of you do not know each other, please go to the discussion section and under the thread "Introductions" introduce yourselves to each other, adding your clinical experience and exposure to psychotropic medications. Please also feel free to add any other questions, thoughts or feelings you have regarding psychiatric medications. 2. What are the ethical issues associated with Counselors discussing medication with clients? What is the landmark case of Osheroff v. Chestnut Lodge and how does this relate to counselors responsibility? 3. Hypothesize why one should be cautious in how one talks to an MD prescriber about medication? What is often most effective in these discussions? 4. What is off label prescribing and what are the associated benefits and dangers Learning Unit 2: Neuroanatomy and neurophysiology, pharmacokinetics and pharmacodynamics. Clinical indicators for pharmacologic interventions. READ: Sinacola, Chapt 2 & 3, and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 2 Respond on the Discussion Board to each of the following: 1. Neurotransmitters are the chemicals responsible for the transmission of all neuronal messages in the body. In an effort to always achieve homeostasis, when the body recognizes an increase in neurotransmitters, it down-regulates, or decreases the number of neurotransmitter receptor sites. Another attempt at maintaining balance is re-uptake. What is re-uptake and how does that explain what a selective serotonin re-uptake inhibitor is? 2. Another equally important role in maintaining homeostasis is played by enzymes, specifically monamine oxidase. Explain the role of monamine oxidase, and therefore why a monamine oxidase inhibitor would be a useful psychotropic medication. 3. What is Cytochrome P-450? How does it impact pharmacokinetics and the rule of One size does not fit all associated with the new field of pharmacogenetics? Learning Unit 3: Treatment of Unipolar Depression: Classical Antidepressants Monamine Oxidase Inhibitors (MAOIS) Tri Cyclic Antidepressants Second Generation Antidepressants: SSRIs: Selective Serotonin reuptake inhibitors Third Generation Antidepressants SDRIs: Selective Dopamine reuptake inhibitors SSNRIs: Selective 5-HT & NE reuptake inhibitors Nonselective cyclic agents READ: Sinacola, chapt 5, and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 3 1. Patients are usually slowly tapered off their antidepressant medications rather than having them abruptly discontinued. Why is this? This is less necessary with drugs such as Prozac which have a longer half life? Why? 2. Discuss why the newer antidepressants such as the SSRIs and cyclic agents have a reduced side effect profile in comparison to the older tricyclic agents? What are typical side effects for SSRIs and how long do they last? 3. The combination of MAOIs and many other psychotropic medications, especially Tricyclic antidepressants causes the same side effects as eating a food containing tyramine. Why is this? Thus the general protocol is to wait two weeks after discontinuing another medication before initiating treatment with an MAOI, or to wait two weeks after discontinuation of an MAOI before initiating treatment with another medication. Please discuss. 4. Briefly summarize the key elements of the following article. How might you use this information? Biology, Meds & Depression-  HYPERLINK "http://www.medscape.com/viewarticle/418726" http://www.medscape.com/viewarticle/418726 (you may need to copy and paste these link into your browser after you sign into Medscape, rather than try to use it as if it is live link.) Learning Unit 4:Treatment of Bipolar Disorder Lithium & Mood Stabilizers (Anticonvulsants) READ: Sinacola, chapt 6, 17 (Ava), and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 4 Due to the fact that the therapeutic level and the toxic level for Lithium are very close, what must become part of the regimen for folks who are treated with LiCo3 (lithium)? How is this done? Why are mood stabilizers added to a typical medication regimen for individuals with BiPolar disorder? What other disorder with psychotic symptoms often benefit from the addition of mood stabilizers.? There are times when it is difficult to differentiate between the symptoms of Lithium toxicity and am impending manic episode. Discuss the similarities and differences. Learning Unit 5: Treatment of Psychotic Disorders Antipsychotics: Typical, Conventional, and Side effects READ: Sinacola, chapt 8, and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 5 1. Anticholinergic and EPS are the two groups of most frequently occurring and bothersome side effects experienced by patients taking Typical/Conventional Antipsychotic medications. Discuss how one of the specific symptoms of either of these side effect groups can be confounded by a patients psychosis making differential diagnosis difficult. 2. Off-label prescribing is a widespread practice in which a physician prescribes a drug (or a medical device) for a purpose different from the one for which the drug has been approved by the Food and Drug Administration (FDA). This practice allows for greater flexibility in the use of medications, but may also have some associated problems. What are some of the off label uses of the typical antipsychotic medications? Discuss some of the potential benefits and difficulties associated with this practice. 3.What is Tardive Dyskinesia? What are the risk factors associated with developing it? First Case exam due following completion of this unit. Learning Unit 6: Treatment of Psychotic Disorders, cont. Antipsychotics: Atypical, Novel, Second Generation, Side effects READ: Sinacola, Chapt 8 (review) & 17 (Stone), and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 6 1. Which antipsychotic medications are available in the long acting depot injectable forms? Why might this be helpful? 2. The newer antipsychotic medications give rise to greater patient compliance due to their reduced side effect profiles (esp. EPS & TD) over the older typical antipsychotic medications. In addition, they also offer a significant improvement in terms of symptom relief. Describe the hypothesis for why this is so, and discuss the symptom reductions. 3. Many patients who receive Medicare, Medicaid, or are under government care (such as in prisons) are treated with the older typical antipsychotics. Why is this, and what does it say about who is in charge of prescribing? 4. Of all the newer atypical, novel or second generation antipsychotic medications, which drug seems to carry the greatest associated risk for weight gain and an increased risk for diabetes? Second Case exam due following completion of this unit. Learning Unit 7: Medicating children & Adolescents Psychotropic issues with children READ: Sinacola, Chapt 9, 15 & 16, and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 7 1. Discuss some of the physiologic, developmental, pharmacokinetic and pharmacodynamic issues associated with medicating children. 2.Which SSRIs have been approved for use with children and/or adolescents? 3.What other medications have been approved for children and adolescentslist associated approved age ranges. Third Case exam due following completion of this unit. Learning Unit 8: Medicating Anxiety, Sleep Disorders, and the Elderly Anxiolytic Agents, Sedative Hypnotics, Cognition enhancers READ: Sinacola, chapt 7, 10, 11, 19 and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 8 1. Benzodiazepines, such as Ativan and Xanax, are more frequently prescribed by GPs and Internists rather than Psychiatrists. Why do you think this is, and what is the problem with this practice? 2. What are some of the physiologic considerations that must be taken into account when medicating elders? Would it be better for them to have a drug with a long or short half life? Why? A growing field in psychopharmacology is the group of drugs called cognition enhancers. Name some of these drugs and discuss how they are hypothesized to work. Fourth Case exam due following completion of this unit. Learning Unit 9: Treating Personality Disorders, Chemical Dependency & Other Disorders READ: Sinacola, chapt 12, 13, & 14, chapt 17 (Candy) and all ppt.s and documents for this LU. Discussion Board Questions: Learning Unit 9 What is the pleasure center, which neurotransmitter is associated with its activation, and how does this relate to substance abuse? There are several drugs that are used in the treatment of substance abuse. What are some of these and how do they work? How effective do they seem to be? Why might they also be used to treat folks with eating disorders? Which groups of medication have been shown to be most effective with folks who have personality disorders that have an impulsive component? What is the hypothesis for this?     .   4 3 4 G H GSV 013ۗۊ~s~d~jh4`hu@OJQJUh4`hu@OJQJh4`hu@5OJQJh4`hu@CJOJQJh.o5CJOJQJh4`h.o50JOJQJ#jh4`h.o5OJQJUjh4`h.o5OJQJUh4`h.o55OJQJh4`h.o5CJOJQJh4`h.o5OJQJh4`h.o5CJOJQJ!.CDM  4 3 4 G H ]  & F h88^8^1$7$8$H$  !1$7$8$H$$a$`` FG 23^_l1$7$8$H$ 1$7$8$H$gdu@ & F`gdu@gdu@ & F h88^83e1^_ >@TA^zʼʼʰʆ|ʆʆʆʆʼnnʆʆah4`hu@CJOJQJhvRhu@5CJOJQJhu@CJOJQJh4`hu@5CJOJQJ!jh4`hu@CJOJQJUh4`hu@OJQJh4`hu@5OJQJh4`hu@6CJOJQJh4`hu@CJOJQJ(h4`hu@6B*CJOJPJQJph%h4`hu@B*CJOJPJQJph&lmFiBfg 1$7$8$H$gdu@1$7$8$H$`gdu@xgdu@gdu@ixgo HLD  ) X!˸yupupudWdudhu@5CJOJQJaJhu@CJOJQJaJ hu@5hu@h4`hu@CJOJQJaJh4`hu@CJOJQJaJh4`hu@5CJOJQJaJ!h4`hu@B*CJOJQJph$h4`hu@5B*CJOJQJphh4`hu@5CJOJQJh4`hu@CJOJQJjh4`hu@OJQJUh4`hu@OJQJ"H  " ####b$d$%%%%% )!)1$7$8$H$^gdu@gdu@gdu@ 1$7$8$H$gdu@X!!!!!!""" # # #########a$b$c$d$n$%%%%"%%%%%) )7)8)H,I,k,Țȍthhh4`hu@5OJQJh4`hu@5CJOJQJh4`hu@OJQJh4`hu@CJOJQJhu@CJOJQJaJhu@B*CJOJQJaJph"hu@5B*CJOJQJaJphhu@hu@CJH*OJQJaJhu@6CJOJQJaJhu@CJOJQJaJhu@5CJOJQJaJ(!)H,I,..;.M..// 2 266"7#7\7|7}77708 1$7$8$H$^ 1$7$8$H$`1$7$8$H$ 7$8$H$^ 7$8$H$gdu@$a$$`a$k,l,..M.// 2 2 26667#7f7p77888888I9999Ŷ襓~kVkVkVkVkVkVk(h4`hu@6B*CJOJPJQJph%h4`hu@B*CJOJPJQJphh4`hu@5OJQJhu@5OJQJ#h4`hu@5>*B*OJQJph!h4`hu@B*CJOJQJphh4`hu@B*OJQJph# h4`hu@6B*OJQJph# #h4`hu@56B*OJQJph# h4`hu@CJOJQJh4`hu@OJQJ0818e88889m9n999999 :;<<<L<r<<<<<gdu@gdu@gdu@$a$gdu@^ 1$7$8$H$^ 1$7$8$H$`1$7$8$H$999 : :-;4;6;_;h;p;;<:<;<<<L<<<<<<<<==> ?ԿԸاwh[M[hh`dhu@5OJQJaJh4`hu@OJQJaJh4`hu@B*OJQJphh4`hu@5OJQJ h4`hu@5B* OJQJph3$h4`hu@5B*OJPJQJph!h4`hu@B*OJPJQJph h_hu@hV9hu@5 hu@5h+-Ihu@5hu@h4`hu@OJQJhu@OJQJ(h4`hu@5B*CJOJPJQJph<<<<<w>x>E?F???/@0@1@z@@@@ A A8ArAsA+C,CDDDgdu@gdu@`gdu@ ??F??.@/@0@B@y@z@@@ A'A(A8A C CDDD>FCFXFFFFFFFqH&J(J2Jòò{ڌòmm_{Whu@B*phhu@5B*OJQJphhu@B*OJPJQJph h4`hu@5B*OJQJph$h4`hu@5B* OJPJQJph3$h4`hu@5B*OJPJQJph!h4`hu@B*OJPJQJphh4`hu@OJQJhu@B*OJQJphh4`hu@B*OJQJphh4`hu@OJQJaJhu@OJQJaJ!DDDE4EOErEEEE!F=F>FFFFGG^gdu@ 1$7$8$H$gdu@h1$7$8$H$^`hgdu@1$7$8$H$^`gdu@1$7$8$H$^`gdu@1$7$8$H$^gdu@gdu@gdu@GpHqH'J(JJJKKKKKLLQLRL~LBM & F 1$7$8$H$gdu@ 1$7$8$H$gdu@`gdu@gdu@gdu@^gdu@8^8gdu@ h^`hgdu@h^hgdu@1$7$8$H$^gdu@^gdu@2J9JoJJJJJJJJKKKKKKKKLLL LL'LPLĮϡϚ~sbOsbObAbhu@B*OJPJQJph$h4`hu@5B*OJPJQJph!h4`hu@B*OJPJQJphh4`hu@OJQJh4`hu@B*OJQJphh4`hu@OJQJaJ hj'hu@hu@0J5OJPJQJ*jhmhu@5OJPJQJUhu@5OJPJQJjhu@5OJPJQJUharChu@5hu@hu@B*phhmhu@6B*phPLQLmLnL~LNN%O&O+OjOOOO#P0PRRRR SS@SDSES|S}SSSSSSSSȷȦȷtttttaYYȦhu@OJQJ$hvRhu@5B* OJPJQJphhu@B*OJQJphh4`hu@B*OJQJphh4`hu@5OJQJh4`hu@OJQJ!h4`hu@B*OJPJQJph h4`hu@5B*OJQJph$h4`hu@5B*OJPJQJph$h4`hu@5B* OJPJQJph3!h xZhu@B*OJPJQJph!BMCM NNNNN%O&OiOjOOPPRRES|S}SSS`gdu@^gdu@`gdu@gdu@gdu@ 1$7$8$H$gdu@ & F 1$7$8$H$gdu@1$7$8$H$^gdu@SSQTRT~TTTTVUV4W5WWWWW/X0XfXXXXXYYgdu@ hh^h`hgdu@h^hgdu@^gdu@1$7$8$H$^gdu@gdu@S(TPTQTRTmTnT}T~T5W8WWWWWWWW/X0X?XCXfXXXXXXXXXXXXYͺ{{{kX{{ͺ$hvRhu@5B* OJPJQJphhu@5B* OJPJQJphh4`hu@OJQJhu@OJQJh4`hu@OJQJaJ h4`hu@5B*OJQJphhu@5B*OJQJph$h4`hu@5B*OJPJQJph$h4`hu@5B* OJPJQJph3!h4`hu@B*OJPJQJphhu@B*OJPJQJph"YYY YXYYYYYYY@ZAZBZHZyZzZZZZչujZG6!h4`hu@B*OJPJQJph$h4`hu@5B*OJPJQJphhu@5B*OJPJQJphh4`hu@OJQJ$hvRhu@5B* OJPJQJphhu@5B* OJPJQJphhu@OJQJhu@OJQJaJh Ahu@B*OJQJphh4`hu@OJQJaJh4`hu@B*OJQJphhu@B*OJQJph h4`hu@5B*OJQJphhu@5B*OJQJphYYYYAZBZyZzZZZZI[J[v[w[=\>\\\]]]]-^.^^gdu@ & F gdu@gdu@^gdu@^gdu@ZZZZZ[[ [I[J[f[u[v[w[[<\\>]Q]]]]]]]༩sksk[Hk$hvRhu@5B* OJPJQJphhu@5B* OJPJQJphhu@OJQJh4`hu@5OJQJh4`hu@OJQJ h4`hu@5B* OJQJph3hu@5B* OJQJph3$h4`hu@5B* OJPJQJph3!h4`hu@B* OJPJQJph3$h4`hu@5B*OJPJQJph!h4`hu@B*OJPJQJphhu@B*OJPJQJph].^3^4^c^^^^^^^?_l_____````````````̭̾{sh\hshshTPTPTPTPh.o5jh.o5Uh4`hu@5OJQJh4`hu@OJQJhu@OJQJ h4`hu@5B* OJQJph3hu@5B* OJQJph3$h4`hu@5B* OJPJQJph3!h4`hu@B* OJPJQJph3hu@B*OJPJQJph!h4`hu@B*OJPJQJph$h4`hu@5B*OJPJQJphhu@5B*OJPJQJph^^^^>_?_``````````````1$7$8$H$^`gdu@^gdu@ & F gdu@gdu@,/ =!"#$% `!4vbdibx., 7x홿kAg;cI!l bX`JP0]@N-ѿ Dll,,d}7sw13{v5Pns1jA&?~N Ǐ&Z AWΞCPhw/.6_YAo]Z [F OT+ǰ@P <WM p$i:u 7MLrYUNxP]ݠK)`aBKq3#w:xJ4ui|Mdaia?z%hr)%j,CMJZ%XhfQU?Q?Q˧KM)B'Jq׸q$N%N@1t;:@͢ݵh[ b:.N BګDL0UCc b%ɪ9$f#X.Idy@E*[JJ_/ gwMAH7H*IR0>@Z]@apG=0k{\E,>/7[8 Ebr[ ֧$ RBo \dH(QX$0 ZXibh0,ڄODJَ91 Etilg8 6 lcńC 'ǀ4daյ_4"ɨ9 Βd.ݿR,m `jr(Ck{ !Đp$>+5mhzC@aiAIĴ"af==跺jjWzomyhD%''I&[+$K?-'jjgL#[GBv?I0vTK>{/+ZahR/xGwmǻ89JDM-X -fYג/ qn4K[X_2Ea|1Ovd?5yٲkIm #qեhl)vW(nvh-u|NmXbalcP:n`BFҀ}ng n˲bw  d.`gK{Oo\mhz~61~Lѭv$%ŷNjfst^1If0[wX`enej9Vˍt&fD]m_mۚSjx@ARq9N8^<&1<$٬2v4]ȽbkfHLaƛ.PfvB/HѵfDBF~{ǔ sfL&@='8%2Xt'U!u 39 -c.`vqP)J}(F2Kا[3zq|5Y1ς[IM\!? C,bȦ!8Y3Z̻^ځ)]i#F#S$HBj߰8OBA M1P$7 ם`.ɟ\vɉPM!.higJUZ2b M6T+q3ŕe|H=JUE]vn0k˨Q*Z aff Ě>\جSkK!(]WAP]f GE.9'FyZν ΃q^ R81.%ʽ1#f6f"`ܚ0e;_uUe(6 MM$@mTSX!#2jt=qRͻCfg3[x宩]4.XSH n OJ fTNIepL3ޡL?:GqB1z75Mk6#8Xw!A^ODM jA/򨊓8rgS9d%ssH̷ ?4j=`m?(JrDyssAozlVbxK^ P16+2x `$ZJ[vvB-I2r#lUP4a[]&-gJV+1 kV,乁]F?1 HisEJ(y-QeFsš6t\ikᛋ-җs+TȰ+{&nvqofE+4s;&RZ*rѭbS.׀h(MAP tˏ.D8,+)Qs.ԕ aJw1xt83аWFNٺx],U^ LWFG;Ek=X&DöAښ={ 't#\@O٢,jN aG*B*c4ma:ɉL!.~W"TeLw =#cep=!2.2RVĒN#T#jw| 8rݖWN% &o-(pg *|S$'xǰ%a8_JͭLT|$7_% ăZ%> }/}'OV[^BSoH>l>:{o{r=U IbhPVʎwV13xogH3^SLƙb_2khv%>_h$S$ _$ `! dnՆ¨U9/I(M| ?x͚=0dǖlţ* TP)&t9%C(cK3v)y[|h$ ! }?Ks5Uzjj.;w}%<~Mit כs> ]%C^[³F=S:ߪ#z"mBvm^e2T 9o`78@ ^yPbW&ޘ7~&tߜ"o I.D#BJ۟#onK.CʑHzVpʪ3^¾z˘X P?կjX//Roc2=p eX9ǣǼE6Z2ѯWv8_O 8JDZw97^n[J*$놡] "|yC;{\јh;^;}ٔwIs<&ؾ!-9rI 3v;)hlě7+J3ۼQ8ZtޤnmLޣtivV8o,+$d[X$#y1.ב@xraD <@-If3%疣R]P|=+]asI1gmYAt0)w!/)T[!ItmtehY❮@6"+͙ޅ* L*ԃV} :ʅ ^I^\sKnfP[o
k&-ͳ˿|W[4*DT7 egyqXj[mYPnkv&t-+p=m!tkoȖ&x~nU|lbwg}gCвh C?ŚPؚN0(M| X xXۊ%YKWuk7>|FA(dQAFaeDQO菘o0Cw5U\ܮ;3sjc5w`w;;ؿ}~X]w~ïˇ,'_JWWBnw__}fx~pM3-̰6t-tuLy)U},}mG0K&-]d"rj m)a^6G={óc&ߡӵZBOj! -Puct_O^fy{eδ1Uv' ݘ=Jwqƌ`Ԧ 3x:ÍKQSz%Cc ?K91X/i}OU ĥ{Ғ?Vب?F\i=P5Պ. Y@ԙ99ՔʦϐZӢIe &3 L2E.l~H ?X,[ dv ӲD~n"&HLRiYXo-Jh5w4'fS4sV'u¯>մ%f{mڦ^kqmA놯ά>pM 7qϚ-d>tsO@=83^q?[Z7x7֣=i&I-To?7Ơum+w7SOJ [l I=)W=\Ѐ]^;̇J}]F<lk/Mw{F3N#;jJ3NK~ӂ`ae_ ZhUR]i5Uw=r\aC fnH]?UzU^'C;wAԦ3tp7GZP:29R Fuv{/=14E_3:LB xZvU-Fjb +1l5,Opp_OPu(o)l`l4 y =o+ڒ\Xۻ>alRO7@Dq l *4^^0jD|9ƚ_ T5Mߊ7LۯٽnI$JF`!) Vx%]lu*bv0  x՚Mh\U$''+PE!"%¥kkv3NAqЍM5AL ."i& hCEopId{9=?7-eYSNj!=h=OvP:QoJ@ fpXZZ1uNfqXrkZhx`tLa = K. 2"&R4_˭@],0DKn8c$|)=qN5p6p !LҶhgXL)sDu.dYS{xNԸ<ۡxU>r}i )n^ƎzrLL$$Hʨt:L'\M[ M_;0j):y4[ d?,58)u8{5Mfӝc0a>bM%Qk\u!Qäqh#&sW"m\ҹQoa#Fqx9u9[t38XN>Xf`$kh&H5BO]AIM`C2&kJ&td%QFk m*52N96+ b>.TwKHR0,zUBp0Pu0SaFEg*&{9,ahd3籊ckMJ2b ZuмȄʄP2$[&B=j @CP3+ZԂ:'>d8$6kCDە+S̥4NOvǸNH7N^}=.E1'`fKEeqe.䋷^NrG6r,Nĺ@XaoNOa5rޤQ#8꫅)5 R'X@vaGiPURXuD&qNM ፈLa &LuL R2'P^Z~!u;wK#U[70I@" :!|u-!oBdQ)~,ـ!qfN>v(V ]+.k' S00! JMj'vd<vMZs|"w0!z*0E0cZcБQ.,F2ws<Dk=`/P݄?m00[EL IÏ "H :W"W6 :3 %]9̭?v`#7!_!r9IݡOIB/8%e`B6\LHxZc\]ԐʻVш?i #6{)q)Ftr1 ˸Co409r/TpE%Dk|9̲6/gCCs t!p[Jϲ{)3"H-*Fg-׻օBL~Hi!@dz,;`v5͎R_\ ^CmS/A-OMi T<v0 xm]lXvǩH$ʬ @@}2>F Pc[ ? Z/ ЧbG)l!X`(@k7zꬅ0,X#jM#4pֽ=32{GNQ/>?0-E&Pÿ~C}I1(6JS1j__ajYDP9NF˿;g~3LZ ~7Mxaǜ 2 XQU2:Nu(D%t/Iosa,ZrqvݱVkcm{m;8h_j._jwss9CC3JU\c b'=a9 8mq ֘/ #L: S2ՠ0"06a(!'_99NvMc7ÁLw'A ujb||xǹ܀Ycvd V+-^qKbNUa_3̾(!^O0Z. \CWcVD;xv0h:7iM4h8$]խ-^]chY1'@*ĉiux{wIb}"wIFdN 6_תׯ@nGlYXƄw!apt^a Ź(515. ;vZcaw_6GRnD%}:c5F1C={ݫm̏fG tކ0wcvoI:d}nmq&H%D"y0'>.y{ྀ"DB<$p믣4&o`xX &t|_y>hR(1Je23\6eg, Qc.T(>N‡4]Xm?T;X= .%'h:`?y6g_l4" A="Qv(5ʌg3rn6 įB x|^ {XT=Z]LՐPݾT'͏ۯؼZ?Şu U($ fExSP.9;陕gsnkKM7,S×+Au;mGv%)X%9ⓢj{`>Sn# U\d;Cz ܳNeLέ~VA΂N.5j6؁quG"\kKLSDO>|!R>0BvU !ZQfbԾ#@vXj N>}";xz6 15l Hvބ ̃repLmv[{XcykPm})No>_XXm6S{zH ;}1_c GD$gOjd<|?'P ݁o8` ,LVהN^p5c8(輀Y@S4 .c_DZێ Z8 SɠƲ>Qg7J|t щAjo0:,rg{ˬ=y\[g8I \vnV6 huy<]x(~jT*n1c&ax/|Չx£We5[*xXCOTIձ!rg,/5@'tZJBlб, m8kbsreKU*Mw<|S>w,쬰hٽH>|8 tUh0m"#(HcMqU \cq/D *b(~Xd]홵._oA"%o>WO?˲?b_|\G-OfH車a dtzx[j@$LNϾg4Q֜KF6z[L1ζr`g@ X'ߗ,pH3S5dXgrTLE@,-̭7+#+[q"DD#abT`"u%}J-/J/#w ?QB' đ(_a)"zk@o M#~`YαF}/)7LSPӱ-ۇ])ț oY8-6*0"U1 G60W#lj=YE&_2!AP%K$ IֱzpN71"D7oA&ǔ??JLlz11)B9uchh-/[RWHy1,ȻzGe bi:dbF/$Ht+(!8kS("I±ZzKA_`|)t;[[U!*f]PG$*uDnoOkk Ye60"l5qhNٱNXP ^Cʤf:”ZRiZSdvmm-(mQT]j.Jڋ:)]{r[!4$Oj"f"`gnmY@+6R5 USbv3sz]6QUPrM 6)HLy%pw~c٨ 2*G4ͺ?:&qb)ؑ<tY ` )!2d{6+sDd,SÁ#A?QƳfo"X(؞.imW?%Xb]%UU0(ڻ+VR)Rh -g`,| V,T6EP; zTQ˻`l`Аe /`Pߘz~0%Y5`H:dd[ږ`AO@>  Heading 5$$@&a$5DA@D Default Paragraph FontViV 0 Table Normal :V 44 la (k( 0No List 0U@0 Hyperlink>*B*4@4 Header  !4 @4 Footer  !DC@"D Body Text Indent `FT@2F Block Text$00]0^0a$2B@B2 Body Text6FV@QF arCFollowedHyperlink >*B*phX.CDM 434GH]FG 23^ _  l m FiBfgH bd !!!H$I$&&;&M&&'' * *.."/#/\/|/}///0010e00001m1n111111 2;4<4L4r444444444w6x6E7F777/80818z8888 9 989r9s9+;,;<<<<<=4=O=r====!>=>>>>>>??p@q@'B(BBBCCCCCDDQDRD~DBECE FFFFF%G&GiGjGGHHJJEK|K}KKKKQLRL~LLLTNUN4O5OOOOO/P0PfPPPPPQQQQQARBRyRzRRRRISJSvSwS=T>TTTUUUU-V.VVVVV>W?WXXXXXXXXXXXXX000H00.000M0M0M0M0M0M0M0M0M0M0M0M 0M 0M 0M 0M 0M 0M0M0M0M0M0M0M 0M 0M 0M0M0M0M0M0M0M0M0M0M0M0M0M0M0M0M0M0M0M00000000000000000000000000000000000000000000000000000000000000000000000000(0(0(0010100<40<40<40<40<40<40<40<40<40<40<40<40<40<40<40<40<40001801801801801801801801801801801801801801880180<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<0<000C0C0C0C 0C0C 0C0C 0C0C80C80C0F0F0F0F0F0F0F0F0F0F0F80C0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K0}K80C00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P00P 00P00P00P80C0U0U0U0U0U0U 0U0U 0U0U 0U0h00Hh00h00Hh00h00Hh00h00Hh00h00` 3X!k,9 ?2JPLSYZ]`1579;=?BCFGIJ l!)08<DGBMSY^`2468:<>@ADEHK`3BBCXXX?2$PvvZ`qu.2$вh C?ŚPݦ2$mS/A-OMi!@&(  J  # A"?J  # A"?J  # A"?B S  ?0 X44QT|'4 _Hlt134936898 OLE_LINK3 OLE_LINK4CRRX@ CSSXW̢$WdWW111X111X=*urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName9*urn:schemas-microsoft-com:office:smarttagsplace $4KSR]3>" 0 G N W [ _ g  BG|9>fk}//1111444466B8N8z88888888;;;;;;;;;;;;+<5<<<<<====r=w=====E>M>O>T>`>e>??@"@N@T@@@@@AAhCpC DDDD0D5DEE,G4G6G;GHGMGGGJJK KKKKL LL0L5LLLPPPPPPIQXQQQRRS S SS(S-SSSSS4VVCVRVWVkVpVXXXXXXXXXXXXX$83dz  BEIX|9>@D@D$$%%&&k((((((1)7)\/d/////e0q0001I1111144z8888=>??BBBBCC%D+DEEE F6G>GKKEK{K8O:OOOOOO.P9P@PBRxRUUXXXXXXXXXXXXX33333333333333333333333333333333333333333333333333333XXXXXXXXXXXXX JzV o.PC&JX~# X,ؐDH1H^%*y59[AB ,zH8j<>eUh$rllK*h ^`OJQJo(h ^`OJQJo(oh pp^p`OJQJo(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJQJo(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJQJo( ^`OJQJo( ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo( hh^h`OJQJo(hh^h`o(. 88^8`hH. L^`LhH.   ^ `hH.   ^ `hH. xLx^x`LhH. HH^H`hH. ^`hH. L^`LhH.h^h`o(. 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.hh^h`OJQJo(hH88^8`OJQJo(hHo^`OJQJo(hH  ^ `OJQJo(hH  ^ `OJQJo(hHoxx^x`OJQJo(hHHH^H`OJQJo(hH^`OJQJo(hHo^`OJQJo(hH0^`0o(. 88^8`hH. L^`LhH.   ^ `hH.   ^ `hH. xLx^x`LhH. HH^H`hH. ^`hH. L^`LhH.h^h`o(. 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. X~#V pPCABX,,zH>eU%*y5DH1$rl( @CJOJQJo(n|@CJOJQJo(                                                       ^x                          *J~ .o5u@yXXy0@X@@Unknown Gz Times New Roman5Symbol3& z Arial7K@Cambriaa M Arial-BoldMSTimes New Roman3Times5Monaco?5 z Courier New;Wingdings 1hc2HD&^@ K-@ K-!4dXX J#q?'X;2>Psychopharmacology for the Non-medical Mental Health Cliniciansyllabus Judith Durham 8         Oh+'0 ( 4@ ` l x @Psychopharmacology for the Non-medical Mental Health Clinician syllabusJudith DurhamNormal 94Microsoft Office Word@bވ'@8|r@ @@ K՜.+,D՜.+,xx   WSpecial Topics syll2010Saint Joseph College-X ?Psychopharmacology for the Non-medical Mental Health Clinician Title< 8@ _PID_HLINKSA r)+http://www.medscape.com/viewarticle/418726 ]xmailto:jdurham@sjc.edu   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghjklmnoprstuvwxyz{|}~Root Entry F`)Data i1TableqWWordDocumentSummaryInformation(DocumentSummaryInformation8CompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89qRoot Entry F!p#Data i1TableqWWordDocument՜.+,D՜.+,xx   WSpecial Topics syll2010Saint Joseph College-X ?Psychopharmacology for the Non-medical Mental Health Clinician Title< 8@ _PID_HLINKSA r)+http://www.medscape.com/viewarticle/418726 ]xmailto:jdurham@sjc.edu SummaryInformation(DocumentSummaryInformation8CompObjq